Elan cuts staff and offices as Tysabri wavers
Irish drugmaker Elan, which recently dropped plans to sell its Elan Drug Technologies operation, has announced job cuts and the closure of offices in a bid to save cash.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs